top
First drug to delay onset of type 1 diabetes made available on NHS
Key takeaways
- Jim Reed Health reporter Family photo Theo Sebastian-Jenkin was diagnosed with type 1 diabetes as a young boy after displaying extreme fatigue, weight loss and other symptoms.
- Teplizumab is a form of immunotherapy that can give people three extra years before they develop symptoms and need lifelong insulin treatment.
- The NHS medicines body described its decision as "genuinely exciting", with hundreds of children and young people likely to benefit each year.
Why this matters: a developing story that could shape the day's news cycle.
Jim Reed Health reporter Family photo Theo Sebastian-Jenkin was diagnosed with type 1 diabetes as a young boy after displaying extreme fatigue, weight loss and other symptoms. The first drug that can delay the onset of type 1 diabetes is being made available on the NHS in England and Wales.
Teplizumab is a form of immunotherapy that can give people three extra years before they develop symptoms and need lifelong insulin treatment.
The NHS medicines body described its decision as "genuinely exciting", with hundreds of children and young people likely to benefit each year.
Article preview — originally published by BBC News. Full story at the source.
Read full story on BBC News →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from BBC News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop